☆ 4.6 Article

Atrial fibrillation: mechanism and clinical management

CHINESE MEDICAL JOURNAL (2023)

Related references

Note: Only part of the references are listed.

Article Cardiac & Cardiovascular Systems

Global burden of atrial fibrillation/atrial flutter and its attributable risk factors from 1990 to 2019

Xin-Jiang Dong et al.

Summary: The aim of this study was to estimate the global burden of atrial fibrillation (AF)/atrial flutter (AFL) and its attributable risk factors from 1990 to 2019. The study found that in 2019, there were 4.7 million incident cases, 8.4 million disability-adjusted life years (DALYs) cases, and 0.32 million deaths of AF/AFL globally. The burden of AF/AFL in 2019 and their temporal trends varied widely due to gender, Socio-Demographic Index (SDI) quintile, and geographical location. High systolic blood pressure was found to be the major risk factor for AF/AFL deaths.

EUROPACE (2023)

Add to Collection

Article Medicine, General & Internal

Effect of Catheter Ablation Using Pulmonary Vein Isolation With vs Without Posterior Left Atrial Wall Isolation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The CAPLA Randomized Clinical Trial

Peter M. Kistler et al.

Summary: This randomized clinical trial compares pulmonary vein isolation (PVI) vs PVI with posterior wall isolation for achieving freedom from atrial arrhythmia in adult patients with persistent atrial fibrillation undergoing first-time catheter ablation in Australia, the UK, and Canada. The study findings suggest that adding posterior wall isolation to PVI does not significantly improve freedom from atrial arrhythmias in patients with persistent AF. Therefore, the empirical inclusion of posterior wall isolation for ablation of persistent AF may not be supported.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Pharmacology and Clinical Development of Factor XI Inhibitors

Antonio Greco et al.

Summary: Therapeutic anticoagulation is used to prevent or treat blood clots, but it can increase the risk of bleeding. Inhibitors of Factor XI (FXI) show promise in reducing the adverse events of anticoagulation. Large-scale phase 3 clinical trials are needed to confirm the role of FXI inhibitors and determine their clinical indications.

CIRCULATION (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial

Atul E. Verma et al.

Summary: Pulsed field ablation is an effective and safe method for treating patients with atrial fibrillation. It has comparable effectiveness to traditional catheter ablation but with a lower rate of complications.

CIRCULATION (2023)

Add to Collection

Review Biology

Advances in basic and translational research in atrial fibrillation

Dan Hu et al.

Summary: Atrial fibrillation (AF) is a common cardiac arrhythmia with a high prevalence worldwide. It is associated with an increased risk of death, stroke, and peripheral embolism. Despite genetic studies identifying AF-associated genes, their definitive impact is not yet established. This review discusses recent advances in understanding and managing AF, including epidemiology, genetics, pathophysiology, and potential treatment options.

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2023)

Add to Collection

Review Cardiac & Cardiovascular Systems

Obesity and atrial fibrillation: Prevalence, pathogenesis, and prognosis

Melissa E. Middeldorp et al.

Summary: The prevalence of atrial fibrillation (AF) and obesity are increasing. There is a shared association between these conditions, with obesity predisposing individuals to shared risk factors. Weight-loss has been shown to have a significant impact on AF symptoms, burden, and the potential to reverse the type of AF. Risk factor management and bariatric surgery offer improved prognosis for patients with AF and obesity. This paper reviews the current data on obesity and AF prevalence, pathogenesis, and prognosis.

PROGRESS IN CARDIOVASCULAR DISEASES (2023)

Add to Collection

Review Endocrinology & Metabolism

Epicardial adipocytes in the pathogenesis of atrial fibrillation: An update on basic and translational studies

Brooks Willar et al.

Summary: Epicardial adipose tissue (EAT) is an endocrine organ that has important physiological functions and can be affected by aging and obesity. There is increasing interest in the relationship between EAT and cardiovascular disease, especially atrial fibrillation. Increased EAT is associated with AF and adverse events after AF ablation.

FRONTIERS IN ENDOCRINOLOGY (2023)

Add to Collection

Article Medicine, General & Internal

Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation

Christian Sohns et al.

Summary: Among patients with atrial fibrillation and end-stage heart failure, catheter ablation combined with guideline-directed medical therapy was associated with a lower likelihood of a composite of death from any cause, implantation of a left ventricular assist device, or urgent heart transplantation compared to medical therapy alone.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Left atrial appendage occlusion

David R. Holmes Jr et al.

Summary: Prevention of stroke is crucial in health systems, and various methods have been developed for different patient groups. These methods include oral anticoagulation, revascularization procedures, device closure, and left atrial appendage occlusion.

EUROINTERVENTION (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? A nationwide cohort study

Tze-Fan Chao et al.

Summary: The aim of this study was to investigate the co-distributions of stroke and bleeding risks in Asian patients with atrial fibrillation (AF) and the clinical benefits of oral anticoagulants (OACs) in AF patients with a single stroke risk factor but at high bleeding risk. The study found that using OACs was still significantly associated with better clinical outcomes in AF patients with an intermediate risk of stroke but at high bleeding risk.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex

Anthony P. Carnicelli et al.

Summary: DOACs have more favorable efficacy and safety profiles compared to warfarin in patients with atrial fibrillation, showing significant advantages in terms of stroke, systemic embolism, and bleeding.

CIRCULATION (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Cryoballoon vs. radiofrequency catheter ablation: insights from NOrwegian randomized study of PERSistent Atrial Fibrillation (NO-PERSAF study)

Li-Bin Shi et al.

Summary: This study evaluated the effectiveness of cryoballoon ablation (CBA) compared to radiofrequency ablation (RFA) in treating persistent atrial fibrillation (AF). The results showed that CBA led to shorter procedure and ablation duration, with less atrial flutter recurrence and similar ATA-free survival rate at 12-month follow-up compared to RFA.

EUROPACE (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

Autonomic Neuromodulation for Atrial Fibrillation Following Cardiac Surgery JACC Review Topic of the Week

Stefanos Zafeiropoulos et al.

Summary: This review critically appraised the current evidence on autonomic neuromodulation therapies (ANMTs) for preventing postoperative atrial fibrillation (POAF) after cardiac surgery. The meta-analysis found that ANMTs can reduce the incidence and burden of POAF, shorten length of stay, and decrease inflammatory response. These findings provide a foundation for future larger and comparative trials of ANMTs.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation

Pavel Osmancik et al.

Summary: The long-term follow-up of the PRAGUE-17 trial demonstrates that left atrial appendage closure is noninferior to direct oral anticoagulants in preventing major cardiovascular, neurological, or bleeding events, and it significantly reduces nonprocedural bleeding.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

The effects of cardiac stretch on atrial fibroblasts: analysis of the evidence and potential role in atrial fibrillation

Xixiao Li et al.

Summary: This article reviews the direct effects of stretch on cardiac fibroblasts, discussing the similarities and differences among studies in observed effects, the signaling pathways involved, and the factors affecting stretch-related phenotypes. The evidence regarding direct fibroblast activation by stretch is deemed weak and inconsistent, and further research is needed to clarify this issue.

CARDIOVASCULAR RESEARCH (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Proton Pump Inhibitor Co-Therapy in Patients with Atrial Fibrillation Treated with Oral Anticoagulants and a Prior History of Upper Gastrointestinal Tract Bleeding

So-Ryoung Lee et al.

Summary: The study found that PPI co-therapy was significantly associated with a reduced risk of major GIB in Asian patients with atrial fibrillation who were treated with oral anticoagulants (OACs) and had a prior history of upper GIB, particularly in patients treated with rivaroxaban and warfarin.

CARDIOVASCULAR DRUGS AND THERAPY (2022)

Add to Collection

Article Endocrinology & Metabolism

Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysis

Chao Li et al.

Summary: The effects of canagliflozin on the incidence of atrial fibrillation/atrial flutter (AF/AFL) and other key cardiorenal outcomes were evaluated in a pooled analysis of the CANVAS and CREDENCE trials. The results showed that canagliflozin did not have a significant effect on AF/AFL incidence overall, but there was a possible reduction in those with no prior history. Additionally, meta-analysis revealed that SGLT2 inhibition reduces the incidence of AF/AFL.

DIABETES OBESITY & METABOLISM (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Effects of intensive blood pressure control on cardiovascular and cognitive outcomes in patients with atrial fibrillation: insights from the SPRINT trial

Chao Jiang et al.

Summary: Patients with atrial fibrillation experience greater cardiovascular benefits with intensive blood pressure control, but may have an increased risk of dementia.

EUROPACE (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

Epicardial adipose tissue in contemporary cardiology

Gianluca Iacobellis

Summary: There is growing interest in the role of epicardial adipose tissue (EAT) in cardiovascular disease. EAT has a protective effect on the myocardium through thermogenic function and can also be harmful by secreting inflammatory and fibrotic cytokines. EAT may also be involved in COVID-19-related cardiac syndrome. It is a modifiable risk factor that can be assessed using different imaging techniques.

NATURE REVIEWS CARDIOLOGY (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

Concomitant surgical ablation for treatment of atrial fibrillation in patients undergoing cardiac surgery

Carmelo Dominici et al.

Summary: Surgical ablation is an effective treatment for atrial fibrillation during cardiac surgery, improving the duration of atrial fibrillation and potentially enhancing quality of life. However, it carries a risk of pacemaker implantation and complications, which should be weighed against individual patient selection. Short-term outcomes support the efficacy of surgical ablation, but further research is needed to investigate long-term effects.

REVIEWS IN CARDIOVASCULAR MEDICINE (2022)

Add to Collection

Review Pharmacology & Pharmacy

NLRP3 and pyroptosis blockers for treating inflammatory diseases

Rebecca C. Coll et al.

Summary: This article reviews the molecular basis of small molecules under development as novel therapeutics to inhibit NLRP3 inflammasome and summarizes recent strategies to block pyroptosis as a new approach to suppress chronic inflammation. Major recent developments include the elucidation of the mechanisms by which small molecules block NLRP3 inflammasome assembly and GSDMD-induced pyroptosis. The status of clinical trials using agents that block specific components of the NLRP3 pathway and their potential clinical applications for the treatment of many diseases are also discussed.

TRENDS IN PHARMACOLOGICAL SCIENCES (2022)

Add to Collection

Article Medicine, General & Internal

Atrial fibrillation

Bianca J. J. M. Brundel et al.

Summary: Atrial fibrillation (AF) is the most common cardiac arrhythmia and is increasing in prevalence. Understanding the molecular mechanisms underlying AF is crucial for the development of personalized diagnostic tools and mechanism-based therapies. Co-creation with patients is essential for successful management of AF.

NATURE REVIEWS DISEASE PRIMERS (2022)

Add to Collection

Article Pharmacology & Pharmacy

Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome

Hao Li et al.

Summary: NOD-like receptor protein 3 (NLRP3) is an important intracellular pattern recognition receptor associated with several human diseases. MCC950, a specific small-molecule inhibitor, blocks activation of the NLRP3 inflammasome. Preclinical and clinical studies have shown promising results for the clinical therapeutic potential of MCC950.

EUROPEAN JOURNAL OF PHARMACOLOGY (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

Inflammasome Signaling in Atrial Fibrillation JACC State-of-the-Art Review

Amir Ajoolabady et al.

Summary: Atrial fibrillation, the most prevalent form of arrhythmia, increases the risk of heart failure, thromboembolism, and stroke. Activation of the NLRP3 inflammasome is associated with the onset and progression of atrial fibrillation.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study

Steven A. Lubitz et al.

Summary: Undiagnosed atrial fibrillation can be detected using a PPG algorithm on wearable devices. The algorithm has a high positive predictive value and can identify individuals at risk for atrial fibrillation.

CIRCULATION (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Randomized Trial of Left Bundle Branch vs Biventricular Pacing for Cardiac Resynchronization Therapy

Yao Wang et al.

Summary: Left bundle branch pacing (LBBP) shows greater improvement in left ventricular ejection fraction (LVEF) compared to biventricular pacing (BiVP) in heart failure patients with nonischemic cardiomyopathy and left bundle branch block (LBBB).

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors on Outcomes After Catheter Ablation for Atrial Fibrillation

Hideyuki Kishima et al.

Summary: This study aimed to examine the effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) on atrial fibrillation (AF) after catheter ablation (CA) in patients with type 2 diabetes mellitus. The results showed that compared to dipeptidyl peptidase-4 inhibitors, SGLT2i achieved greater suppression of AF recurrence.

JACC-CLINICAL ELECTROPHYSIOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

Gerhard Hindricks et al.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Review Hematology

The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): A Novel Approach to In-Depth Characterization (Rather than Classification) of Atrial Fibrillation

Tatjana S. Potpara et al.

Summary: Atrial fibrillation (AF) is a complex condition that requires comprehensive management involving multiple treatment decisions. While the widely used classification based on episode duration and patterns has contributed to better understanding of AF, there is a recognized need for a more multidimensional classification system as treatment options become more complex. The proposal of a structured characterization approach aims to streamline assessment, communication among physicians, and treatment decision-making for optimal management of AF patients.

THROMBOSIS AND HAEMOSTASIS (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Cardiac Pressure Overload Decreases ETV1 Expression in the Left Atrium, Contributing to Atrial Electrical and Structural Remodeling

Naoko Yamaguchi et al.

Summary: This study revealed that ETV1 is downregulated in the left atrium during cardiac pressure overload, contributing to both electrical and structural remodeling.

CIRCULATION (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Atrial fibrillation-a complex polygenetic disease

Julie H. Andersen et al.

Summary: Atrial fibrillation (AF) is the most common type of arrhythmia with a substantial genetic component. Over 160 genes have been associated with AF, including rare genetic variants that play a significant role in the disease. Emerging research is challenging traditional understanding of AF, potentially leading to improved diagnostics and treatment in the future.

EUROPEAN JOURNAL OF HUMAN GENETICS (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Marshall bundle elimination, Pulmonary vein isolation, and Line completion for ANatomical ablation of persistent atrial fibrillation (Marshall-PLAN): Prospective, single-center study

Nicolas Derval et al.

Summary: This study found that a novel ablation strategy targeting anatomical atrial structures (VOM ethanol infusion, PVI, and prespecified linear lesions) is feasible, safe, and associated with a high rate of freedom from arrhythmia recurrence at 12 months in patients with persistent AF.

HEART RHYTHM (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Neuroscientific therapies for atrial fibrillation

Peter Hanna et al.

Summary: The cardiac autonomic nervous system is crucial in cardiac physiology and disease, with therapies targeting the cardiac neuraxis showing promising results in pre-clinical and clinical studies.

CARDIOVASCULAR RESEARCH (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it

Stanley Nattel et al.

Summary: Atrial fibrillation is the most common sustained clinical arrhythmia, contributing significantly to population morbidity and mortality. Current therapies for rhythm control are not optimally effective or safe, requiring the use of preclinical models for development of improved treatment options. Despite insights gained from extensive research, translating mechanistic discoveries into clinically applicable safe and effective therapies has proven challenging.

CARDIOVASCULAR RESEARCH (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Alcohol Consumption Reduction and Clinical Outcomes of Catheter Ablation for Atrial Fibrillation

Yoshihide Takahashi et al.

Summary: This study suggests that reduction in alcohol consumption is associated with improved clinical outcomes of catheter ablation for atrial fibrillation (AF), with a reduction of >= 1% showing lower risk of AF/atrial tachycardia (AT) recurrence.

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

Jan Steffel et al.

EUROPACE (2021)

Add to Collection

Review Cell Biology

Atrial Cardiomyopathy: Pathophysiology and Clinical Consequences

Andreas Goette et al.

Summary: This article summarizes the underlying pathophysiology and remodeling processes observed in the development of atrial cardiomyopathy, thrombogenesis, and atrial fibrillation, focusing particularly on the impact of oxidative stress, inflammation, diabetes, and obesity.

CELLS (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation A Meta-analysis of Randomized Clinical Trials

Mohit K. Turagam et al.

Summary: This study evaluates the safety and efficacy of atrial fibrillation ablation as a first-line therapy compared with antiarrhythmic drugs in early rhythm control of patients with paroxysmal atrial fibrillation.

JAMA CARDIOLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

How does the level of pulmonary venous isolation compare between pulsed field ablation and thermal energy ablation (radiofrequency, cryo, or laser)?

Iwanari Kawamura et al.

Summary: This study compared the efficacy of pulsed field ablation and thermal ablation technologies in terms of pulmonary vein isolation, and found that there was no significant difference between the two methods in terms of left and right pulmonary vein isolation areas and the non-ablated posterior wall area.

EUROPACE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial

Michele Brignole et al.

Summary: Ablation + CRT treatment is superior in reducing all-cause mortality in severely symptomatic permanent AF patients. Furthermore, this treatment also significantly lowers the combined endpoint of all-cause mortality or HF hospitalization.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Efficacy of the stand-alone Cox-Maze IV procedure in patients with longstanding persistent atrial fibrillation

Martha M. O. McGilvray et al.

Summary: The study demonstrates that the Cox-Maze IV procedure (CMP-IV) has excellent efficacy in treating patients with longstanding persistent atrial fibrillation (AF), even in cases where patients have a long duration of preoperative AF and have failed prior catheter ablation. Late recurrence of atrial tachyarrhythmias post-surgery is associated with preoperative AF duration and early postoperative atrial tachyarrhythmias.

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Atrial fibrillation and autonomic nervous system: A translational approach to guide therapeutic goals

Marco Rebecchi et al.

Summary: The autonomic nervous system plays a significant role in atrial fibrillation, with treatments such as catheter ablation and nerve stimulation showing promising results. However, it is important to consider dynamic factors and lifestyle choices when developing therapeutic strategies for ANS modulation. New approaches such as antiarrhythmic drugs, gene therapy, and ablatogenomics offer exciting prospects for future treatment options.

JOURNAL OF ARRHYTHMIA (2021)

Add to Collection

Article Medicine, Research & Experimental

Vagus Nerve Stimulation and the Cardiovascular System

Michael J. Capilupi et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Atrial fibrillation and cardiac fibrosis

Christian Sohns et al.

EUROPEAN HEART JOURNAL (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Epicardial adipose tissue and atrial fibrillation: Possible mechanisms, potential therapies, and future directions

Mengmeng Zhou et al.

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Physical activity, cardiorespiratory fitness, and cardiovascular outcomes in individuals with atrial fibrillation: the HUNT study

Lars E. Garnvik et al.

EUROPEAN HEART JOURNAL (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation

Yutao Guo et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Animal Models of Atrial Fibrillation

Dominik Schuettler et al.

CIRCULATION RESEARCH (2020)

Add to Collection

Article Peripheral Vascular Disease

Effect of Intensive Blood Pressure Lowering on the Risk of Atrial Fibrillation

Elsayed Z. Soliman et al.

HYPERTENSION (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial

Shouvik Haldar et al.

EUROPEAN HEART JOURNAL (2020)

Add to Collection

Article Genetics & Heredity

Meta-analysis of Transcriptomic Data Reveals Pathophysiological Modules Involved with Atrial Fibrillation

Rodrigo Haas Bueno et al.

MOLECULAR DIAGNOSIS & THERAPY (2020)

Add to Collection

Article Medicine, General & Internal

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation

Paulus Kirchhof et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Cellular and mitochondrial mechanisms of atrial fibrillation

Fleur E. Mason et al.

BASIC RESEARCH IN CARDIOLOGY (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Hybrid Convergent Procedure for the Treatment of Persistent and Long-Standing Persistent Atrial Fibrillation Results of CONVERGE Clinical Trial

David B. DeLurgio et al.

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Galectin-3 in Cardiovascular Diseases

Valeria Blanda et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Medicine, General & Internal

Alcohol Abstinence in Drinkers with Atrial Fibrillation

Aleksandr Voskoboinik et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Epicardial adipose tissue affects the efficacy of left atrial posterior wall isolation for persistent atrial fibrillation

Yosuke Nakatani et al.

JOURNAL OF ARRHYTHMIA (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Atrial fibrillation and cardiac fibrosis

Christian Sohns et al.

EUROPEAN HEART JOURNAL (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial

Shouvik Haldar et al.

EUROPEAN HEART JOURNAL (2020)

Add to Collection

Article Medicine, General & Internal

Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation The CABANA Randomized Clinical Trial

Daniel B. Mark et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Add to Collection

Review Cardiac & Cardiovascular Systems

Catheter Ablation Versus Medical Therapy for Atrial Fibrillation A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Zain Ul Abideen Asad et al.

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2019)

Add to Collection

Review Cardiac & Cardiovascular Systems

Atrial Fibrillation and Diabetes Mellitus JACC Review Topic of the Week

Allen Wang et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Add to Collection

Review Oncology

Apple Watch, Wearables, and Heart Rhythm: where do we stand?

Joel M. Raja et al.

ANNALS OF TRANSLATIONAL MEDICINE (2019)

Add to Collection

Article Medicine, General & Internal

Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation

Marco V. Perez et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Letter Medicine, General & Internal

Reassessment of Risk for Stroke During Follow-up of Patients With Atrial Fibrillation

Tze-Fan Chao et al.

ANNALS OF INTERNAL MEDICINE (2019)

Add to Collection

Review Cardiac & Cardiovascular Systems

Risk stratification for stroke in atrial fibrillation: a critique

Ammar M. Killu et al.

EUROPEAN HEART JOURNAL (2019)

Add to Collection

Review Neurosciences

Sympathetic Nervous System Activation and Its Modulation: Role in Atrial Fibrillation

Revathy Carnagarin et al.

FRONTIERS IN NEUROSCIENCE (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation

Chunxia Yao et al.

CIRCULATION (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Thirty-Second Gold Standard Definition of Atrial Fibrillation and Its Relationship With Subsequent Arrhythmia Patterns Analysis of a Large Prospective Device Database

Jonathan S. Steinberg et al.

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2018)

Add to Collection

Article Medicine, General & Internal

Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation The mSToPS Randomized Clinical Trial

Steven R. Steinhubl et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

Add to Collection

Article Medicine, General & Internal

Catheter Ablation for Atrial Fibrillation with Heart Failure

Nassir F. Marrouche et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Article Medicine, General & Internal

Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation

Karl-Heinz Kuck et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification

Gareth J. Wynn et al.

EUROPACE (2014)

Add to Collection

Article Critical Care Medicine

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation The Euro Head Survey

Ron Pisters et al.

CHEST (2010)

Add to Collection

Article Critical Care Medicine

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation

Gregory Y. H. Lip et al.

CHEST (2010)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

In patients with atrial fibrillation are allowed less rigorous control of ventricular rate.

Blazej Kozlowski

KARDIOLOGIA POLSKA (2010)

Add to Collection

Article Medicine, General & Internal

Lenient versus Strict Rate Control in Patients with Atrial Fibrillation.

Isabelle C. Van Gelder et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Add to Collection

© Peeref 2019-2024. All rights reserved.